发明名称 Demonstrable Efficacy Across or Within Patient Populations
摘要 The present invention provides methods for improving observed or determined efficacy by administration of agents to more severely diseased subjects, as contrasted with less severely diseased subjects. The present disclosure specifically demonstrates that, with respect to treatment of certain skin conditions, and particularly conditions associated with dysregulated and/or diseased skin cells, administration to more severely diseased subjects improves observed or determined efficacy.
申请公布号 US2015313536(A1) 申请公布日期 2015.11.05
申请号 US201514702269 申请日期 2015.05.01
申请人 Anterios, Inc. 发明人 Edelson Jonathan
分类号 A61B5/00;A61K9/00;G06Q99/00;A61K38/48 主分类号 A61B5/00
代理机构 代理人
主权项 1. A method of improving demonstrable effectiveness of a treatment, the method comprising steps of: a) determining stratification of subjects into two or more categories based on disease or condition severity, so that a first category corresponds to relatively severe disease or condition relative to at least one second category; and b) administering the treatment to subjects in the first category and not to subjects in at least one second category.
地址 New York NY US